The new facility in Pfizer is designed to allow the Ringaskiddy site to manufacture tailored drugs that will work with your genetic code to beat illnesses.

Pfizer has opened a new $30m (€21.6m) facility at its Ringaskiddy plant that will allow the company to manufacture the next generation of cancer, cholesterol and blood-thinning drugs.